Public Company News

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound ...

2021-09-17 20:00 4918

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355

BEIJING, Sept. 17, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies called Tiannuojiancheng Pharm...

2021-09-17 20:00 5900

RYB Education, Inc. Reports Second Quarter 2021 Financial Results

BEIJING, Sept. 17, 2021 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced its unaudited financial results for the second quarter of 2021. Second Quarter 2021 Operational and Financial Summary ...

2021-09-17 20:00 18051

RYB Education, Inc. Announces Change of Board Composition

BEIJING, Sept. 17, 2021 /PRNewswire/ -- RYB Education, Inc. ("RYB" or the "Company") (NYSE: RYB), a leading early childhood education service provider in China, today announced the resignation of Mr. Chimin Cao as the chairman of the board of directors (the "Board") of the Company and the re-desi...

2021-09-17 20:00 18055

111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that Senior Vice President, Investor Relations and...

2021-09-17 19:00 4766

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021

HONG KONG, Sept. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2021-09-17 19:00 19246

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management p...

2021-09-17 18:30 15457

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management p...

2021-09-17 18:30 2282

"Captain Tsubasa: Dream Team" Dream Championship 2021 Online Qualifiers Kick Off Today

TOKYO, Sept. 17, 2021 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that the Japanese and global versions ofCaptain Tsubasa: Dream Team will hold the worldwide Dream Championship 2021 tournament and will kick off its online qualifiers starting today. Additionally, special ...

2021-09-17 18:15 2144

Tarena to Report Second Quarter of 2021 Financial Results on September 24, 2021

BEIJING, Sept. 17, 2021 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU) ("Tarena" or the "Company"), a leading provider of adult professional education and childhood and adolescent quality education services inChina, today announced that it will report its unaudited financial results fo...

2021-09-17 18:00 14940

The Joint Venture between ReneSola Power and Eiffel Investment Group Acquires Its First 200 MW Project Portfolio

STAMFORD, Conn., Sept. 17, 2021 /PRNewswire/ -- ReneSola Ltd ("ReneSola Power" or the "Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that European Solar Energy Development JV, the joint venture co...

2021-09-17 18:00 3584

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based inTokyo, boasts over 25,000 associates worldwide, providing products and services to more than 160 countries and regions across...

2021-09-17 15:30 3942

Right Issue to Develop Ultra-Micro Ecosystem, A New Source of Growth Amidst the Pandemic

JAKARTA, Indonesia, Sept. 17, 2021 /PR Newswire/ - PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) has come up with strategies to accelerate the UMi (Ultra-Micro Holding) ecosystem inIndonesia, following the official formation of UMi holding onSeptember 13, 2021. BRI's three main strategies al...

2021-09-17 15:26 9078

BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone

VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...

2021-09-17 15:00 6337

The Way to Best LCOE (IV)

CHANGZHOU, China, Sept. 17, 2021 /PRNewswire/ -- Recently, Fraunhofer ISE, the world leading solar institution, has completed the assessment of CAPEX and LCOE of new generation of ultra-high power modules 210mm (G12) fromTrina Solar and 182mm (M10) series from other manufacturer. Founded in...

2021-09-17 13:24 4826

Dada Group Launches Smart Delivery SaaS System to accelerate delivery digitalization

SHANGHAI, Sept. 16, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("DADA"), China's leading local on-demand delivery and retail platform, today announced the launch of its open digital logistics platform, Dada Smart Delivery SaaS System. Based on Dada Now's self-developed Smart Logistics System ...

2021-09-17 11:54 3477

Red ginseng selected as the most popular Chuseok (Korean Thanksgiving day) gift in Korea

SEOUL, South Korea, Sept. 17, 2021 /PRNewswire/ -- KGC (Korea Ginseng Corp), which makes the No. 1 red ginseng brand, CheongKwanJang in Korea, announced that the most popular Chuseok gift in Korea is red ginseng. The announcement was based on Korea Health SupplementsAssociation. According to the ...

2021-09-17 08:36 8249

Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021

SAN FRANCISCO and SUZHOU, China, Sept. 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-17 08:00 6942

CStone will present registrational clinical study data of Sugemalimab in patients with stage III non-small cell lung cancer in an oral presentation at ESMO Congress 2021

* Sugemalimab is the world's first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients withstage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * The data showed that suge...

2021-09-17 08:00 4420

Everest Medicines, Sinovent and SinoMab Announce Licensing Agreement for Global Development, Manufacturing and Commercialization of Novel BTK Inhibitor in Renal Diseases

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest") announced today that it has entered into an exclusive licensing agreement with Suzhou Sinovent Pharmaceuticals Co., Ltd. ("Sinovent") an...

2021-09-17 06:30 6875

Week's Top Stories